Home / Codeine, Combinations excl. Psycholeptics / Canada
CA ATC N02AA59 · updated 2 Nov 2026
Codeine, Combinations excl. Psycholeptics shortage in Canada
Is there a Codeine, Combinations excl. Psycholeptics shortage in Canada?
Yes. As of 2 Nov 2026, 5 Codeine, Combinations excl. Psycholeptics products are reported short in Canada, the first since 1 Mar 2013. No return date has been given. Main reason: manufacturing problem.
Not reported short in any other country we track. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | METHOXISAL-C 1/2 (100) | TEVA CANADA LIMITED | 1 Mar 2013 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | METHOXISAL-C 1/2 (24) | TEVA CANADA LIMITED | 1 Dec 2013 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | METHOXISAL-C 1/4 (24) | TEVA CANADA LIMITED | 1 Dec 2013 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | METHOXISAL-C 1/8 (18) | TEVA CANADA LIMITED | 1 Dec 2013 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | ROBAXISAL C 1/2 (250) | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | 5 Jul 2021 | not given | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.